Indeed, we show that vaccination with TA-CIN/GPI-0100 elicits a robust CD4 T cell proliferative response in mice, and proliferative responses to TA-CIN are also observed in patients. The gene discussed is CD4; the disease is cervical squamous intraepithelial neoplasia.